RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis

Male osteoporosis is an increasingly recognized problem in aging men. A common cause of male osteoporosis is hypogonadism. Thousands of men with prostate cancer are treated with androgen deprivation therapy, a treatment that dramatically reduces serum testosterone and causes severe hypogonadism. Men...

Full description

Saved in:
Bibliographic Details
Main Authors: Alicia K. Morgans, Matthew R. Smith
Format: Article
Language:English
Published: Wiley 2011-01-01
Series:Journal of Osteoporosis
Online Access:http://dx.doi.org/10.4061/2011/941310
Tags: Add Tag
No Tags, Be the first to tag this record!